332386-68-2

Upstream product

• 70424-94-1 methyl 3,4,5-tris(benzyloxy)benzoate 
• 79831-88-2 3,4,5-tribenzyloxybenzyl alcohol 
• 6137-86-6 3,4,5-tribenzyloxybenzaldehyde 
• 332386-67-1 ethyl (E)-3,4,5-tris(benzyloxy)cinnamate 

Downstream Products

• 1374304-26-3 (E)-3-[3,4,5-tris(benzyloxy)phenyl]prop-2-enal 
• 1374304-27-4 (E)-2-[3,4,5-tris(benzyloxy)phenyl]ethenyl-1,3-oxathiolane 
• 1350703-20-6 3-(3,4,5-trihydroxyphenyl)propyl β-D-glucopyranoside 
• 332386-76-2 Bn-(+)-EGCG 
• 332386-77-3 (-)-(2R,3R)-cis-5,7-bis(benzyloxy)-2-[3,4,5-tris(benzyloxy)phenyl]chroman-3-yl 3,4,5-tris(benzyloxy)benzoate 
• 332386-57-9 (1R,2R)-3-[2,4-Bis-benzyloxy-6-(tert-butyl-dimethyl-silanyloxy)-phenyl]-1-(3,4,5-tris-benzyloxy-phenyl)-propane-1,2-diol 
• 942122-64-7 (1S,2S)-3-[2,4-bis(benzyloxy)-6-(tert-butyldimethylsilyloxy)phenyl]-1-[3,4,5-tris(benzyloxy)phenyl]propane-1,2-diol 
• 332386-55-7 (E)-3-[2,4-bis(benzyloxy)-6-(tert-butyldimethylsilyloxy)phenyl]-1-[3,4,5-tris(benzyloxy)phenyl]propene 
• 1027171-15-8 3,5-Bis-benzyloxy-2-[(4R,5R)-2-ethoxy-5-(3,4,5-tris-benzyloxy-phenyl)-[1,3]dioxolan-4-ylmethyl]-phenol 
• 332386-59-1 (+)-(1R,2R)-3-[2,4-bis(benzyloxy)-6-hydroxyphenyl]-1-[3,4,5-tris(benzyloxy)phenyl]propane-1,2-diol 
• 332386-60-4 (-)-(1S,2S)-3-[2,4-bis(benzyloxy)-6-hydroxyphenyl]-1-[3,4,5-tris(benzyloxy)phenyl]propane-1,2-diol 
• 332386-71-7 (-)-(2R,3S)-trans-5,7-bis(benzyloxy)-2-[3,4,5-tris(benzyloxy)phenyl]chroman-3-ol 
• 332386-74-0 (-)-(2R,3R)-cis-5,7-bis(benzyloxy)-2-[3,4,5-tris(benzyloxy)phenyl]chroman-3-ol 

Relevant academic research and scientific papers

General and convenient approach to flavan-3-ols: Stereoselective synthesis of (-)-gallocatechin

General synthetic route to flavan-3-ols was developed. Union of two fragments was accomplished by an efficient three-step protocol, enabling the stereoselective synthesis of (-)-gallocatechin. Copyright

Enantioselective synthesis of epigallocatechin-3-gallate (EGCG), the active polyphenol component from green tea.

[reaction: see text]. Enantioselective synthesis of epigallocatechin-3-gallate (EGCG, 3b), the active polyphenol component from green tea, has been achieved by using a stereospecific cyclization of the Sharpless asymmetric dihydroxylation product 7c as the key step.